Glenn Crater, MD, FCCP

Interim Chief Medical Officer, Director

Chief Medical Officer of Innospera Pharma and a board-certified pulmonologist with more than 25 years of clinical, regulatory, and leadership experience. Previously served as Chief Medical Officer at multiple biotechnology companies, contributing to successful regulatory submissions and advancing clinical programs in respiratory and fibrotic diseases.